Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122716844 | 12271684 | 4 | F | 201604 | 20160708 | 20160415 | 20160713 | PER | US-CELGENEUS-USA-2016043003 | CELGENE | 73.30 | YR | M | Y | 98.97000 | KG | 20160713 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122716844 | 12271684 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 40555 | 21660 | 125 | MG/M**2 | INJECTION | |||||
122716844 | 12271684 | 2 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 40555 | 21660 | INJECTION | |||||||
122716844 | 12271684 | 3 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | Y | U | UNKNOWN | 55974 | 1000 | ML | UNKNOWN | |||||
122716844 | 12271684 | 4 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | Y | U | UNKNOWN | 55974 | UNKNOWN | |||||||
122716844 | 12271684 | 5 | SS | M402 (Necuparanib) | NECUPARANIB | 1 | Unknown | Y | U | 40555 | 0 | 5 | MG/KG | UNKNOWN | |||||
122716844 | 12271684 | 6 | SS | M402 (Necuparanib) | NECUPARANIB | 1 | Unknown | Y | U | 40555 | 0 | UNKNOWN | |||||||
122716844 | 12271684 | 7 | C | Oxycodone | OXYCODONE | 1 | Unknown | 400 MILLIGRAM | 0 | 10 | MG | UNKNOWN | Q4H | ||||||
122716844 | 12271684 | 8 | C | Morphine | MORPHINE | 1 | Intravenous drip | 0 | 2 | MG | INJECTION | ||||||||
122716844 | 12271684 | 9 | C | GUAIFENESIN. | GUAIFENESIN | 1 | Oral | 10MG 10 ML | 0 | UNKNOWN | Q4H | ||||||||
122716844 | 12271684 | 10 | C | LIDOCAINE. | LIDOCAINE | 1 | Topical | 0 | UNKNOWN | ||||||||||
122716844 | 12271684 | 11 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | Oral | 0 | 500 | MG | UNKNOWN | TID | |||||||
122716844 | 12271684 | 12 | C | Ondansetron | ONDANSETRON | 1 | Oral | 0 | 8 | MG | UNKNOWN | Q8H | |||||||
122716844 | 12271684 | 13 | C | Ondansetron | ONDANSETRON | 1 | Oral | 0 | 6 | MG | UNKNOWN | Q8H | |||||||
122716844 | 12271684 | 14 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 300 | MG | TABLETS | QD | |||||||
122716844 | 12271684 | 15 | C | Amiodarone | AMIODARONE | 1 | Oral | 60 MILLIGRAM | 0 | 200 | MG | TABLETS | QD | ||||||
122716844 | 12271684 | 16 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 2 MILLIGRAM | 0 | 81 | MG | TABLETS | QD | ||||||
122716844 | 12271684 | 17 | C | Cholecalciferol | CHOLECALCIFEROL | 1 | Oral | 0 | 1000 | IU | TABLETS | QD | |||||||
122716844 | 12271684 | 18 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Oral | 0 | 400 | MG | TABLETS | QD | |||||||
122716844 | 12271684 | 19 | C | Melatonin | MELATONIN | 1 | Oral | 0 | 3 | MG | TABLETS | QD | |||||||
122716844 | 12271684 | 20 | C | NEBIVOLOL. | NEBIVOLOL | 1 | Oral | 0 | 10 | MG | TABLETS | QD | |||||||
122716844 | 12271684 | 21 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | 40 | MG | TABLETS | QD | |||||||
122716844 | 12271684 | 22 | C | TOPIRAMATE. | TOPIRAMATE | 1 | Oral | 0 | 50 | MG | TABLETS | BID | |||||||
122716844 | 12271684 | 23 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 1500 MILLIGRAM | 0 | 50 | MG | TABLETS |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122716844 | 12271684 | 1 | Pancreatic carcinoma stage IV |
122716844 | 12271684 | 3 | Pancreatic carcinoma stage IV |
122716844 | 12271684 | 5 | Pancreatic carcinoma stage IV |
122716844 | 12271684 | 7 | Stomatitis |
122716844 | 12271684 | 8 | Stomatitis |
122716844 | 12271684 | 9 | Product used for unknown indication |
122716844 | 12271684 | 10 | Product used for unknown indication |
122716844 | 12271684 | 11 | Product used for unknown indication |
122716844 | 12271684 | 12 | Product used for unknown indication |
122716844 | 12271684 | 14 | Product used for unknown indication |
122716844 | 12271684 | 15 | Product used for unknown indication |
122716844 | 12271684 | 16 | Product used for unknown indication |
122716844 | 12271684 | 17 | Product used for unknown indication |
122716844 | 12271684 | 18 | Product used for unknown indication |
122716844 | 12271684 | 19 | Product used for unknown indication |
122716844 | 12271684 | 20 | Product used for unknown indication |
122716844 | 12271684 | 21 | Product used for unknown indication |
122716844 | 12271684 | 22 | Product used for unknown indication |
122716844 | 12271684 | 23 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122716844 | 12271684 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122716844 | 12271684 | Colitis | |
122716844 | 12271684 | Hypotension | |
122716844 | 12271684 | Neutropenia | |
122716844 | 12271684 | Pneumonia | |
122716844 | 12271684 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122716844 | 12271684 | 1 | 20160322 | 20160328 | 0 | |
122716844 | 12271684 | 2 | 20160328 | 20160404 | 0 | |
122716844 | 12271684 | 3 | 20160322 | 20160328 | 0 | |
122716844 | 12271684 | 4 | 20160328 | 20160404 | 0 | |
122716844 | 12271684 | 5 | 20160322 | 20160403 | 0 | |
122716844 | 12271684 | 6 | 20160404 | 20160404 | 0 | |
122716844 | 12271684 | 9 | 20160406 | 0 | ||
122716844 | 12271684 | 10 | 20160406 | 0 | ||
122716844 | 12271684 | 11 | 20160406 | 0 | ||
122716844 | 12271684 | 12 | 20160406 | 0 |